soilDBdata
soilDBdata exists so soilDB's tests can run without a NASIS connection.
Comparison · Analytics
medrobust vs medsim
A side-by-side editorial comparison of medrobust and medsim — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:r package
medrobust vs medsim: at a glance
What is medrobust?
medrobust made its partial-identification bounds usable by giving them confidence intervals.
medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.
What is medsim?
medsim is turning simulation runs into auditable artifacts, not just fast ones.
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
medrobust vs medsim: editorial side-by-side
medrobust
0.0ANALYTICS
medrobust made its partial-identification bounds usable by giving them confidence intervals.
◆ Current state
medrobust computes partial-identification bounds for mediation effects when exposure or mediator is differentially misclassified, part of the Data-Wise mediationverse. Its 0.2.0 release corrected three estimator defects against population oracles and added Imbens-Manski confidence intervals for the bounds; the two releases since have paired each identification path with a real public-domain dataset and a worked vignette. CRAN is deferred, with distribution through GitHub and r-universe.
◆ Where it's heading
The pattern is deliberate and symmetric: 0.3.0 shipped the mediator-side example on NCHS natality data, 0.4.0 its exposure-side mirror on NHANES, each demonstrating what the bounds do when reporting accuracy is allowed to depend on the outcome. Alongside that runs a consistent concern with failing usefully rather than loudly — bound_ne() returns NA bounds with a machine-readable reason and a typed condition instead of aborting, so a simulation replicate is recorded rather than lost, and non-finite endpoint standard errors produce a documented NA rather than a silent one. That is a package expecting to be run thousands of times inside someone else's loop.
◆ Prediction
Both identification paths now have a dataset, a vignette and interval coverage, so the next release is most likely the deferred CRAN submission rather than new methodology.
medsim
6.3ANALYTICS
medsim is turning simulation runs into auditable artifacts, not just fast ones.
◆ Current state
medsim is a young Monte Carlo harness for mediation-analysis simulation studies, first tagged in May 2026 and already at 0.5.1. The last two releases moved the package's center of gravity from running simulations to proving a run is trustworthy: chunk provenance headers, a single-SHA assertion across chunks, and a pilot-subset positive control. The statistical work sits in the missing-data line added in 0.2.0 — Fleishman non-normal generators, rate-calibrated MCAR/MAR/MNAR amputation, and a validated D4-stacked MBCO estimator.
◆ Where it's heading
The arc is toward defensible HPC runs: each 0.5.x gate closes a way a cluster job could silently produce wrong output, and 0.5.1 extends the same suspicion to the estimator itself by exposing the branch disagreement the standard ARIV averages away. Releases are cadenced against discovered defects rather than a roadmap — 0.5.0 cites seven findings from a pre-integration review, and 0.5.1 cites an adversarial review of 0.5.0. The audit surface is widening faster than the method surface.
◆ Prediction
The collapse-audit exclusion list has now been patched twice for method-specific diagnostic columns, so the next likely move is a contract letting methods declare their own discrete fields instead of medsim naming them centrally.
Alternatives to medrobust and medsim
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either medrobust or medsim.
collinear
collinear has broken its API twice to stop making the user pick thresholds.
nert
nert put fourteen TERN datasets behind one dispatcher and called it stable.
scTypeEval
scTypeEval judges single-cell annotations without needing a ground truth to judge them against.
probmed
probmed went from one probabilistic effect size to a family of them in sixteen days.
fluxnet-package
fluxnet keeps swapping its own plumbing — first a Python downloader, now a DuckDB backend.
See all medrobust alternatives → · See all medsim alternatives →
Recent activity from medrobust and medsim
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 7h agomedsimmedsim 0.5.1 — fixed-branch ARIV
- 16d agomedsimmedsim 0.5.0 — chunked-run integrity ⚡
- 1mo agomedsimseed= now honored in sequential fallback paths
- 2mo agomedrobustNHANES exposure-side misclassification example dataset
- 2mo agomedrobustNatality example dataset; bounds degrade instead of aborting
- 2mo agomedrobustBounds corrected against oracles; Imbens-Manski intervals added ⚡
- 2mo agomedsimDocs and dependency metadata synced to the 0.2.0 state
- 2mo agomedsimMissing-data mediation: amputation, non-normal DGMs, D4-MBCO ⚡
- 3mo agomedsimv0.1.1 — cleanup release
Frequently asked questions
What is the difference between medrobust and medsim?
Both compete on the same themes — r package — within Analytics. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is medrobust better than medsim?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. medsim is currently shipping more aggressively (velocity 6.3 vs 0.0), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to medrobust?
Top medrobust alternatives in Analytics are ranked by recent ship velocity. Browse the "medrobust alternatives" section above for the current picks, or visit /alternatives/medrobust for the full list with editorial commentary on each.
What are the best alternatives to medsim?
Top medsim alternatives in Analytics are ranked by recent ship velocity. Browse the "medsim alternatives" section above for the current picks, or visit /alternatives/medsim for the full list with editorial commentary on each.